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VERNALIZATION1 (VRN1) is required in the model plant Arabidopsis
thaliana for the epigenetic suppression of the floral repressor FLC by prolonged
cold treatment. Stable suppression of FLC accelerates flowering, a physiological
process known as vernalization. VRN1 is a 341-residue DNA-binding protein
that contains two plant-specific B3 domains (B3a and B3b), a putative nuclear
localization sequence (NLS) and two putative PEST domains. VRN1208–341
includes the second B3 domain and a region upstream that is highly conserved in
the VRN1 orthologues of other dicotyledonous plants. VRN1208–341 was
crystallized by the hanging-drop method in 0.05M sodium acetate pH 6.0
containing 1.0M NaCl and 18%(w/v) PEG 3350. Preliminary X-ray diffraction
data analysis revealed that the VRN1208–341 crystal diffracted to 2.1 A˚ and
belonged to space group C2, with unit-cell parameters a = 105.2, b = 47.9,
c = 61.2 A˚, = 90.0, = 115.4,  = 90.0. Assuming that two molecules occupy the
asymmetric unit, a Matthews coefficient of 2.05 A˚3 Da1 and a solvent content
of 40.1% were calculated.
1. Introduction
Vernalization is a physiological process in which prolonged cold
(namely winter) accelerates flowering. In Arabidopsis, vernalization
is predominantly achieved by repressing the MADS-box floral
repressor FLOWERING LOCUS C (FLC; Michaels & Amasino,
1999; Sheldon et al., 1999). Using molecular-genetic approaches,
Arabidopsis vernalization has been shown to require a number of
proteins including VIN3, a plant homeodomain (PHD) finger protein
whose expression is induced by prolonged cold (Sung & Amasino,
2004), VRN5, a VIN3-related protein that is constitutively expressed
(Greb et al., 2007; Sung, Schmitz et al., 2006), VRN2, a homologue of
the Polycomb protein Su(z)12, a well characterized chromatin regu-
lator in Drosophila and humans (Gendall et al., 2001), and
VERNALIZATION1 (VRN1), a DNA-binding protein (Levy et al.,
2002). Maintenance of FLC silencing also requires the Arabidopsis
homologue of HETEROCHROMATIN PROTEIN1 (Mylne et al.,
2006; Sung, He et al., 2006). Recently, TAP-tagged VRN5 was found
to be able to pull down a complex of proteins including the afore-
mentioned VRN2 and VIN3 with Polycomb core proteins FIE (an
ESC homologue), MSI1 (a p55 homologue) and a PHD-finger protein
VEL1 (De Lucia et al., 2008). Vernalization stably suppresses FLC
via changes to the histones associated with the FLC locus, which
result in the mitotic stability of vernalization (Bastow et al., 2004;
Sung & Amasino, 2004).
VRN1 is a plant-specific protein and so far appears to only have
dicotyledonous homologues. VRN1 possesses two B3 DNA-binding
domains, putative PEST protein-turnover domains and nuclear
localization sequences (Levy et al., 2002). Overexpression of VRN1
protein does not affect the requirements for vernalization but caused
very deformed and early flowering plants, revealing that VRN1 needs
other factors to suppress FLC and that VRN1 has additional roles in
plant development (Levy et al., 2002). In vitro, recombinant full-
length VRN1 protein was shown to bind naked dsDNA in a non-
sequence-specific manner (Levy et al., 2002). A fully functional
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genomic VRN1-GFP fusion associated throughout the nucleus in
vivo and remained associated with mitotic chromosomes (Mylne et
al., 2006). Immunolocalization showed VRN1 to be excluded from
heterochromatic chromocentres. VRN1 protein dissociated from
nuclei undergoing meiosis and this was supported by a dramatic drop
in mRNA expression in pollen (Mylne et al., 2006).
Although full-length VRN1 protein may be produced in Escher-
ichia coli, it is unstable and even rapidly prepared protein extracts
exhibit degradation. Following purification from the degraded forms,
full-length VRN1 continues to degrade in vitro. We produced a stable
134-residue fragment VRN1208–341 which includes the second B3
domain (B3b) and a region upstream that is both highly conserved in
the VRN1 orthologues of other dicotyledonous plants and predicted
to possess helical secondary structure. Here, we report the crystal-
lization and preliminary X-ray analysis of A. thaliana VRN1208–341.
2. Materials and methods
2.1. Expression and purification
A plasmid pET19b-V1 (Levy et al., 2002) containing a full-length
A. thaliana VRN1 (At3g18990) open reading frame was PCR
amplified using primers JM91 (50-GAA TTC GGT ACC GGA TCC
CGT TCA AAG TTC TAC GAG AGT GCT-30) and JM93 (50-ACG
CAC GCA CGC GTC GAC TCA GAC GTA CTC GTT GAC TCG
AAA-30). The product was digested with BamHI and SalI (sites
shown in bold in the primer sequences above) and ligated into the
BamHI/SalI sites of pQE30 (Qiagen). This construct introduces
an N-terminal sequence MRGSHHHHHHGS to the 134 residues of
VRN1 from Arg208 to Val341 (total deduced molecular weight of
16 988 Da).
The pQE30-VRN1208–341 plasmid (JMDNA27) and pREP4
(Qiagen) were co-transformed into E. coli strain BL21 (Novagen)
and selected on 100 mg ml1 ampicillin and 35 mg ml1 kanamycin
Luria–Bertani (LB) agar plates. A single colony was picked and
grown overnight at 310 K in 40 ml LB broth containing 100 mg ml1
ampicillin and 35 mg ml1 kanamycin. This culture was split to start
two separate 500 ml LB cultures containing 100 mg ml1 ampicillin
and 35 mg ml1 kanamycin. When the cultures had reached log-phase
growth (OD600 nm = 0.8), they were moved to 289 K and VRN1208–341
protein expression was induced by addition of isopropyl -d-1-thio-
galactopyranoside to 1 mM and growth overnight.
Cells were pelleted and resuspended in 50 mM Tris–HCl pH 8.0,
1M sodium chloride, 30 mM imidazole, 10 mM benzamidine hydro-
chloride and lysed by five passes through a French press at 6.9 MPa.
The lysate was cleared by centrifugation and loaded onto a PolyPrep
column (BioRad) containing 3 ml chelating (Ni–NTA) Sepharose
(GE Heathcare) pre-loaded with 10 ml 100 mM nickel sulfate. The
column was washed with 50 ml 50 mM Tris–HCl pH 8.0, 1M sodium
chloride, 30 mM imidazole and the VRN1208–341 protein was eluted
from the column with 11 ml 50 mM Tris–HCl pH 8.0, 1M sodium
chloride, 250 mM imidazole. The protein was further purified by size-
exclusion chromatography using a Sephacryl S100 column (GE
Healthcare) in buffer containing 50 mM sodium phosphate pH 7.0,
150 mM NaCl and 1 mM DTT. Pure VRN1208–341 was dialysed into
10 mM HEPES pH 7.0, 50 mM sodium chloride, 5 mM DTT and
concentrated for crystallization by centrifugation in an Amicon
Ultra-4 concentrator with a 5 kDa cutoff (Millipore). A Coomassie-
stained gel of the purified VRN1208–341 protein is shown in Fig. 1(a).
2.2. Crystallization
Crystallization-condition screening was performed at 293 and
277 K using the following eight commercial screening kits:
Systematically Controlled Crystallization Screen Set 101 (Axygen
Bioscience), Index Screen and SaltRx (Hampton Research), JCSG
Plus and Pact Premier (Molecular Dimensions Ltd), Precipitant
Synergy (Emerald Biosystems) and Wizard I and II (Emerald Bios-
tructures). The hanging-drop vapour-diffusion method was used and
drops were set up using a Mosquito (TTP Labtech) on ViewDrop II
(TTP Labtech) seals in 96-well titre plates (TPP) containing 85 ml
well solution. The hanging drop was comprised of 100 nl well solution
and 100 nl protein solution (34 mg ml1, A280 = 34) in 10 mMHEPES
pH 7.0 containing 50 mM sodium chloride and 5 mM DTT. Crystal-
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Figure 1
(a) Coomassie-stained gel with low molecular-weight markers (GE Healthcare; labelled in kDa) and VRN1208–341 protein at two different concentrations: 1 ml (lane 1) and
5 ml (lane 2). (b) Cluster of VRN1208–341 crystals obtained in 0.05M sodium acetate pH 6.0 containing 1.0M NaCl and 18%(w/v) PEG 3350 using the hanging-drop vapour-
diffusion method. The scale bar corresponds to 0.2 mm.
lization experiments were stored and imaged using two RockImagers
(Formulatrix), with one set at 277 K and the other at 293 K.
Optimization experiments were set up in 24-well VDXm plates
(Hampton Research) that contained 400 ml well solution; the drop
was comprised of 1 ml protein solution and 1 ml well solution on
siliconized glass cover slides (Hampton Research).
Crystals were placed in cryo-solution [sodium acetate pH 4.5
containing 1.0M NaCl, 20%(w/v) PEG 3350 and 20%(v/v) ethylene
glycol] for less than a minute before being placed directly in the cryo-
stream.
2.3. Data collection and refinement
Diffraction data were collected on a Rigaku FR-E copper rotating-
anode generator operated at 45 kV and 45 mA with Osmic Confocal
Vari-Max HFoptics at a wavelength of 1.5418 A˚. The crystal was kept
at 100 K during data collection using a CRYO Industries of America
CRYOCOOL-LN2 gas-stream cooler. 360 images were collected with
’ = 0.5 and a crystal-to-detector distance of 60 mm. The detector
was a Rigaku Saturn 944 CCD.
Data were processed using CrystalClear 1.4 (Rigaku Corporation).
3. Results and discussion
In the initial screening trials, six conditions were found to produce
crystalline precipitate at the two temperatures (277 and 293 K):
Systematically Controlled Crystallization Screen Set 101 conditions
79 and 88 at 277 K, Index Screen conditions 9 and 10 at 277 K and
Pact Premier conditions 35 and 61 at 277 and 293 K, respectively. Five
of these conditions were reproduced in an optimization round that
again used the hanging-drop format.
Optimization experiments for Systematically Controlled Crystal-
lization Screen Set 101 conditions 79 and 88 were designed in a
shallow-gradient format and used to generate crystals for diffraction
studies.
VRN1208–341 crystals grown using conditions based on the com-
mercial condition Systematically Controlled Crystallization Screen
Set 101 condition 79 [0.05M sodium acetate pH 5.0 containing
15%(v/v) PEG 3350 and 1.0M NaCl] appeared as clusters (Fig. 1b)
from which single crystals could be separated for X-ray diffraction
studies. A crystal (0.2  0.05  0.05 mm) separated from a cluster
grown at 277 K in 0.05M sodium acetate pH 6.0 containing 1.0M
NaCl and 18%(w/v) PEG 3350 (based on condition 79) diffracted to
2.1 A˚ resolution (Table 1, Fig. 2). The crystal belonged to space group
C2 with unit-cell parameters a = 105.2, b = 47.9, c = 61.2 A˚,  = 90.0,
 = 115.4,  = 90.0. Assuming the presence of two protein molecules
per asymmetric unit, acceptable values were obtained for the
Matthews coefficient (2.05 A˚3 Da1) and solvent content (40.1%;
calculated using http://www.scripps.edu/cgi-bin/cdputnam/protcalc3;
Matthews, 1968).
VRN1208–341 is thought to comprise a B3 domain; two structures
have been determined of the B3 domains of RAV1 (Yamasaki et al.,
crystallization communications
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Table 1
Summary of data-collection statistics.
Values in parentheses are for the last resolution shell.
Space group C2
Unit-cell parameters (A˚, ) a = 105.2, b = 47.9, c = 61.2,
 = 90.0,  = 115.4,  = 90.0
Mosaicity () 0.78
Resolution range (A˚) 31.07–2.10 (2.18–2.10)
Total No. of reflections 47904
Unique reflections 15246
Average redundancy 3.14 (2.08)
Completeness (%) 93.6 (80.3)
Rmerge† 0.080 (0.176)
hI/(I)i 9.5 (3.7)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
Figure 2
Diffraction image from native VRN1208–341 (Cu K, wavelength = 1.5418 A˚). An enlargement of the boxed region is shown on the right. The crystal diffracted to 2.1 A˚
resolution.
2004) and At1g16640 (Waltner et al., 2005). Despite only sharing 26%
sequence identity, the tertiary structures of these two B3 domains are
similar (backbone r.m.s.d. ’ 2 A˚; Waltner et al., 2005). Both struc-
tures were determined using NMR spectroscopy; this report there-
fore describes the first crystallization of a B3-domain protein.
The 99-amino-acid B3-domain region of VRN1208–341 (i.e. VRN1
Phe243–Val341) has 25% identity to the B3 domain of RAV1 and
18% identity to At1g16640. Attempts to use these two NMR struc-
tures (RAV1, PDB code 1wid; At1g16640, PDB code 1yel) as models
for a molecular-replacement solution of these VRN1208–341 data using
Phaser (McCoy, 2007) have so far failed. We are therefore planning to
produce an SeMet derivative of this protein for structure determi-
nation by SAD or MAD phasing.
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